Convergent antibody responses to SARS-CoV-2 in convalescent individuals

Keywords

AntibodyVirologyConvalescent plasmaVirusEpitopeSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Neutralizing antibodyBiologyNeutralizationCoronavirusCoronavirus disease 2019 (COVID-19)Spike ProteinImmunologyReceptorMedicineDiseaseInfectious disease (medical specialty)Internal medicineGenetics

Affiliated Institutions

Related Publications

Structural Basis of Neutralization by a Human Anti-severe Acute Respiratory Syndrome Spike Protein Antibody, 80R

W.C. Hwang , Yaqiong Lin , Eugenio Santelli +6 more

Severe acute respiratory syndrome (SARS) is a newly emerged infectious disease that caused pandemic spread in 2003. The etiological agent of SARS is a novel coronavirus (SARS-Co...

2006 Journal of Biological Chemistry 231 citations

Antigenic and Immunogenic Characterization of Recombinant Baculovirus-Expressed Severe Acute Respiratory Syndrome Coronavirus Spike Protein: Implication for Vaccine Design

Yuxian He , Jingjing Li , Susanne Heck +2 more

ABSTRACT The spike (S) glycoprotein of severe acute respiratory syndrome coronavirus (SARS-CoV) mediates the receptor interaction and immune recognition and is considered a majo...

2006 Journal of Virology 135 citations

NVX-CoV2373 vaccine protects cynomolgus macaque upper and lower airways against SARS-CoV-2 challenge

Mimi Guebre‐Xabier , Nita Patel , Jing-Hui Tian +10 more

There is an urgent need for a safe and protective vaccine to control the global spread of SARS-CoV-2 and prevent COVID-19. Here, we report the immunogenicity and protective effi...

2020 Vaccine 238 citations

Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen

Jesper Pallesen , Nianshuang Wang , Kizzmekia S. Corbett +15 more

Significance Coronaviruses such as Middle East respiratory syndrome coronavirus (MERS-CoV) cause severe respiratory distress with high fatality rates. The spike (S) glycoprotein...

2017 Proceedings of the National Academy o... 1186 citations

The novel coronavirus 2019 (2019-nCoV) uses the SARS-coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells

Markus Hoffmann , Hannah Kleine‐Weber , Nadine Krüger +3 more

Abstract The emergence of a novel, highly pathogenic coronavirus, 2019-nCoV, in China, and its rapid national and international spread pose a global health emergency. Coronaviru...

2020 bioRxiv (Cold Spring Harbor Laboratory) 754 citations

Publication Info

Year: 2020
Type: article
Volume: 584
Issue: 7821
Pages: 437-442
Citations: 2095
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Convergent antibody responses to SARS-CoV-2 in convalescent individuals

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

2095

OpenAlex

Cite This

APA Style

                            
                                
                                    Davide F. Robbiani, 
                                
                                    Christian Gaebler, 
                                
                                    Frauke Muecksch
                                
                                et al.
                            
                            (2020). 
                            Convergent antibody responses to SARS-CoV-2 in convalescent individuals. 
                            Nature
                            , 584
                            (7821)
                            , 437-442.
                            https://doi.org/10.1038/s41586-020-2456-9
                        

Identifiers

DOI: 10.1038/s41586-020-2456-9